Channel Therapeutics Corpora
13F holders, Q1 2024 (March 31)1holders
$2.62avg. 13F price*
At the end of Q1 2024, 1 institutions reported holding Channel Therapeutics Corpora in their 13F filings. The largest holder was Anson Funds Management LP ($660K).
- Company
- Channel Therapeutics Corpora
- Filed as
- CHROMOCELL THERAPEUTICS CORP COM (Q1 2024)
- CUSIP
- 171126105
- Latest filing quarter
- Q2 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $660K |
| Exits | 0 | $0 |
Ownership 1 holders
| Anson Funds Management LP | 0.05% | New | 251,888 | $660K |
"% of holder's portfolio" is CHANNEL THERAPEUTICS CORPORA's weight in each manager's 13F, not the share of Channel Therapeutics Corpora the manager owns.